February 9, 2026 · Form 4 insider transaction
McFarlane Neil F. sold 14,625 shares of KemPharm Incorporated at $8.56 per share, a transaction worth $125.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Adoption date of referenced 10b5-1(c) plan is: 3/21/2025.; This transaction was executed in multiple trades at prices ranging from $8.39 to $8.67. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.